Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.
about
Role of lysophosphatidic acid and its receptors in the kidney.Co-stimulation of LPAR1 and S1PR1/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases.Fatty acid receptor modulator PBI-4050 inhibits kidney fibrosis and improves glycemic control.
P2860
Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@en
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@nl
type
label
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@en
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@nl
prefLabel
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@en
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@nl
P2093
P2860
P356
P1476
Lysophosphatidic Acid Receptor ...... hy in a Type 2 Diabetic Model.
@en
P2093
Agnes B Fogo
Bradley Zinker
Brian J Murphy
Haichun Yang
Ming-Zhi Zhang
Peter Cheng
Raymond C Harris
Robert Kaltenbach
P2860
P304
P356
10.1681/ASN.2017010107
P577
2017-07-24T00:00:00Z